Matthew Stapelkamp, PA-C
NPI 1942795620 · Physician Assistant · New York, NY
Enrolled with Medicare as Practitioner - Physician Assistant · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Matthew Stapelkamp, PA-C is a Physician Assistant provider in New York, NY (NPI 1942795620).
Provider details
- NPI number
- 1942795620
- Entity type
- Individual
- Primary specialty
- Physician AssistantPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- PA-C
- Sex
- Male
- Sole proprietor
- No
- License
- 022120 (NY)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Physician Assistants & Advanced Practice Nursing Providers
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
7 yrs in NPPES registry
- Profile completeness33% of score
100% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Tamsulosin Hcl | 105 | 51 |
| Oxycodone Hcl/Acetaminophenbrand: Oxycodone-Acetaminophen | 40 | 40 |
| Sulfamethoxazole/Trimethoprimbrand: Sulfamethoxazole-Trimethoprim | 33 | 33 |
| Mirabegronbrand: Myrbetriq | 25 | — |
| Finasteride | 24 | 13 |
| Estradiol | 13 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$283 across 7 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2018-06-26
- Last updated
- 2019-12-09
- Certified
- 2019-12-09
Frequently asked questions
- What is Matthew Stapelkamp's NPI number?
- Matthew Stapelkamp's National Provider Identifier (NPI) is 1942795620, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Matthew Stapelkamp's specialty?
- Matthew Stapelkamp is listed in the NPPES registry with a primary specialty of Physician Assistant (Physician Assistants & Advanced Practice Nursing Providers).
- Where is Matthew Stapelkamp located?
- Matthew Stapelkamp's practice location on file with NPPES is 1000 10th Ave, New York, NY 10019.
- What is Matthew Stapelkamp's phone number?
- The practice phone number listed in the NPPES registry for Matthew Stapelkamp is (212) 523-4000.
- Does Matthew Stapelkamp accept Medicare?
- Matthew Stapelkamp is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Matthew Stapelkamp's NPI active?
- Yes — Matthew Stapelkamp's NPI (1942795620) is active in the NPPES registry as of the last update on 2019-12-09.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.